Cite
HARVARD Citation
Aguirre, L. et al. (2021). It is time to shift the treatment paradigm in myelodysplastic syndromes: A focus on novel developments and current investigational approaches exploring combinatorial therapy in high-risk MDS. Baillière's best practice and research in clinical haematology. 34 (4), p. . [Online].